Evidence-Based Approach to One Health Vaccinology
Only a few human vaccine trials have been reported from the least developed countries. The target population of biological products often does not have the same opportunity to participate in pre-and post-licensing studies (1). The COVID-19 vaccine trials may have been exceptional. At the same time,...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Razi Vaccine and Serum Research Institute
2021-12-01
|
| Series: | Archives of Razi Institute |
| Subjects: | |
| Online Access: | https://archrazi.areeo.ac.ir/article_125643_e013e2a97480cfa8e48c837d568b3c48.pdf |